Search Results - "Kaneto, Hideaki"
-
1
Pancreatic β-cell glucose toxicity in type 2 diabetes mellitus
Published in Current diabetes reviews (01-01-2015)“…Pancreatic β-cells secrete insulin when blood glucose levels become high. However, when β-cells are chronically exposed to hyperglycemia, their function…”
Get more information
Journal Article -
2
Multifaceted Mechanisms of Action of Metformin Which Have Been Unraveled One after Another in the Long History
Published in International journal of molecular sciences (05-03-2021)“…While there are various kinds of drugs for type 2 diabetes mellitus at present, in this review article, we focus on metformin which is an insulin sensitizer…”
Get full text
Journal Article -
3
Dulaglutide exerts beneficial anti atherosclerotic effects in ApoE knockout mice with diabetes: the earlier, the better
Published in Scientific reports (14-01-2021)“…There has been no report about the mechanism for anti-atherosclerotic effects of dulaglutide (Dula) and/or about the difference of its effectiveness between in…”
Get full text
Journal Article -
4
Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis
Published in Mediators of Inflammation (01-01-2010)“…Type 2 diabetes is the most prevalent and serious metabolic disease all over the world, and its hallmarks are pancreatic β-cell dysfunction and insulin…”
Get full text
Journal Article -
5
Metformin induces insulin secretion by preserving pancreatic aquaporin 7 expression in type 2 diabetes mellitus
Published in Journal of diabetes investigation (01-02-2022)“…In the presence of metformin, the c‐Jun‐NH2‐terminal kinase and p38 pathways in β‐cells are inhibited, resulting in preserved aquaporin 7 expression and…”
Get full text
Journal Article -
6
Role of pancreatic transcription factors in maintenance of mature β-cell function
Published in International journal of molecular sciences (18-03-2015)“…A variety of pancreatic transcription factors including PDX-1 and MafA play crucial roles in the pancreas and function for the maintenance of mature β-cell…”
Get full text
Journal Article -
7
Comparison of the effects of three kinds of glucose‐lowering drugs on non‐alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open‐label, three‐arm, active control study
Published in Journal of diabetes investigation (01-11-2020)“…Aims/Introduction Non‐alcoholic fatty liver disease (NAFLD) is often observed in individuals with type 2 diabetes mellitus, and it is known that the presence…”
Get full text
Journal Article -
8
Practical application of short-term intensive insulin therapy based on the concept of “treat to target” to reduce hypoglycaemia in routine clinical site
Published in Scientific reports (31-01-2020)“…The aim is to devise a new short-term intensive insulin therapy (N-SIIT) based on the concept of “treat to target” to avoid hypoglycaemia and was applied it to…”
Get full text
Journal Article -
9
Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice
Published in Scientific reports (09-08-2021)“…Effects of combination therapy of dipeptidyl peptidase-4 (DPP-4) inhibitor and sodium-glucose co-transporter 2 (SGLT2) inhibitor on β-cells are still unclear,…”
Get full text
Journal Article -
10
Imeglimin exerts favorable effects on pancreatic β-cells by improving morphology in mitochondria and increasing the number of insulin granules
Published in Scientific reports (02-08-2022)“…Imeglimin is a new anti-diabetic drug commercialized in Japan (Twymeeg®) and has been drawing much attention in diabetes research area as well as in clinical…”
Get full text
Journal Article -
11
Unexpected Pleiotropic Effects of SGLT2 Inhibitors: Pearls and Pitfalls of This Novel Antidiabetic Class
Published in International journal of molecular sciences (17-03-2021)“…Sodium-glucose co-transporter 2 (SGLT2) inhibitors facilitate urine glucose excretion by reducing glucose reabsorption, leading to ameliorate glycemic control…”
Get full text
Journal Article -
12
Clinical course of different long-acting insulin therapies—glargine U100, U300, degludec, and insulin degludec/insulin aspart—among Japanese patients with type 2 diabetes: a multicenter retrospective observational study (JDDM65 study)
Published in Endocrine Journal (01-01-2022)“…This study aimed to retrospectively compare the clinical efficacy of different types of long-acting insulin therapies—glargine U100, glargine U300, degludec,…”
Get full text
Journal Article -
13
Significance of body mass index for diagnosing sarcopenia is equivalent to slow gait speed in Japanese individuals with type 2 diabetes: Cross‐sectional study using outpatient clinical data
Published in Journal of diabetes investigation (01-03-2021)“…Aims/Introduction This study examined the association between body mass index (BMI) and the risk of sarcopenia in Japanese type 2 diabetes patients. Materials…”
Get full text
Journal Article -
14
Favorable Effects of GLP-1 Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: “The Earlier, the Better” in Therapy with Incretin-Based Medicine
Published in International journal of molecular sciences (01-08-2021)“…Fundamental pancreatic β-cell function is to produce and secrete insulin in response to blood glucose levels. However, when β-cells are chronically exposed to…”
Get full text
Journal Article -
15
Case Report: Markedly Long-Term Preservation of Pancreatic β-Cell Function in a Subject With Elderly Onset of Type 1 Diabetes Mellitus Showing High-Titer Autoimmune Antibodies for Over 4 Years
Published in Frontiers in immunology (25-11-2021)“…Type 1 diabetes mellitus (T1DM) is mainly triggered by autoimmune β-cell destruction, usually leading to absolute insulin deficiency. Regarding the speed of…”
Get full text
Journal Article -
16
Pancreatic alpha cells in diabetic rats express active GLP-1 receptor: Endosomal co-localization of GLP-1/GLP-1R complex functioning through intra-islet paracrine mechanism
Published in Scientific reports (27-02-2018)“…Glucagon-like peptide-1 (GLP-1) stimulates insulin secretion from pancreatic beta cells and suppresses glucagon secretion from alpha cells. It remains…”
Get full text
Journal Article -
17
Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trials
Published in Journal of diabetes investigation (01-06-2022)“…Aims/Introduction To assess the impact of baseline characteristics on the efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes…”
Get full text
Journal Article -
18
Impact of sarcopenia on glycemic control and atherosclerosis in Japanese patients with type 2 diabetes: Cross‐sectional study using outpatient clinical data
Published in Geriatrics & gerontology international (01-12-2020)“…Aim This study examined the association among sarcopenia and various surrogate markers of atherosclerosis in Japanese patients with type 2 diabetes (T2D)…”
Get full text
Journal Article -
19
Obesity and Dyslipidemia Synergistically Exacerbate Psoriatic Skin Inflammation
Published in International journal of molecular sciences (13-04-2022)“…Patients with psoriasis are frequently complicated with metabolic syndrome; however, it is not fully understood how obesity and dyslipidemia contribute to the…”
Get full text
Journal Article -
20
Influence of Nutritional Guidance/Consulting on Glycemic Control during the Coronavirus Disease 2019 Pandemic in Patients with Type 2 Diabetes Mellitus
Published in Internal Medicine (15-03-2023)“…Objective The coronavirus disease 2019 (COVID-19) pandemic has led to a global restriction of public behavior due to lockdowns in various major cities…”
Get full text
Journal Article